The Department of Medicine recently hired Jeff and Jenny Klomp, lead authors of groundbreaking research on the gene KRAS and its impact on pancreatic, lung, and colorectal cancers. Their research could lead to effective treatments, better prediction of treatment responses, and new strategies to overcome drug resistance in KRAS-driven cancers.
People who work in health care believe in continuous improvement. And when there’s an opportunity for health care experts to partner with researchers at academic institutions and related companies, great things can happen.
For decades, Kathy Steece-Collier, PhD, professor of translational neuroscience, has been researching ways to improve the quality of life for Parkinson’s patients. Her work has led to a new gene therapy that could reduce or eliminate symptoms. Evidence also suggests this therapy has potential to halt progression of the disease.
NIH funding supports groundbreaking biomedical and public health research at MSU College of Human Medicine. Today’s Rally for Medical Research Hill Day raises awareness of the critical need for robust, sustained, and predictable funding increases for the National Institutes of Health. Join medical research advocates in keeping NIH funding a national top priority.
Researcher Xiaopeng Li, PhD, in collaboration with researchers from Corewell Health and Cleveland Clinic, have made a significant breakthrough in understanding post-COVID-19 lung complications.
A $2 million investment by the Mall Family Foundation has empowered the recruitment of genetic autism research expert Lucas Pozzo-Miller, PhD, to the College of Human Medicine as the inaugural Mall Family Endowed Professor in Genetic Autism Research.
The College of Human Medicine Department of Obstetrics, Gynecology and Reproductive Biology ranked number one in funding from the National Institutes of Health (NIH) in 2023, according to the new Blue Ridge Institute for Medical Research report.
The U.S. Food and Drug Administration has approved a drug to treat neuroblastoma, an often-fatal pediatric cancer, based on pioneering research by College of Human Medicine professor André Bachmann.
A recent Rapid Growth article highlights to new wave of medical innovation happening in downtown Grand Rapids and the health care partnerships that have flourished, including those happening at the MSU Grand Rapids Innovation Park.
Executive Vice President for Health Sciences Norman J. Beauchamp Jr., MD, alumnus and former dean of the College of Human Medicine, and Jack Lipton, PhD, professor and founding chair of the Department of Translational Neuroscience, were named “Notable West Michigan Leaders in Health Care.”
As part of its relocation to downtown Grand Rapids this year, digital consulting firm Twisthink LLC has formed a partnership with new neighbor Spartan Innovations to lend engineering and development services to startups. Proximity to each other in the Doug Meijer Medical Innovation Building leads to an ecosystem of innovation.
College of Human Medicine professor André Bachmann and two Corewell Health physicians, Caleb Bupp and Surender Rajasekaran, have been named the 2023 Inventors of the Year for their discovery of a previously unknown disease and development of an effective treatment.
Spartan Innovations and Rockford Construction recently hosted a grand opening celebration for The Bridge, a highly-anticipated incubator space located on the fourth floor of the Doug Meijer Medical Innovation Building.
MSU's Grand Rapids-based medical hub gains steam, Spartan Innovations, tech consulting firm Twisthink to open this year in seven-story building.
Bold Advanced Medical Futures (BAMF) Health celebrated the official grand opening of their headquarters at the Doug Meijer Innovation Center at a private launch event on Oct. 5.
Doug Meijer’s own cancer journey inspired him to support the MSU College of Human Medicine’s mission, by bringing the world’s most advanced medical technology to MSU for cancer treatment.
The new Perrigo corporate headquarters located at MSU's Innovation Park will bring over 150 jobs to Grand Rapids.
Michigan's first total body PET/CT scanner has arrived at the Michigan State University Radiopharmacy in the Doug Meijer Medical Innovation Building.
Jack Lipton, PhD, is a co-leader of a $1.87 million MI-SAPPHIRE award to expand coronavirus surveillance in the state of Michigan.
Jeremy Prokop, PhD, will partner with Spectrum Health to leverage bioinformatics to detect, track and better understand future coronavirus variants.
The New Community Transformation Fund is investing $500,000 in BAMF, a groundbreaking medical startup located at the Grand Rapids Innovation Park.
The Doug Meijer Medical Innovation Building is a monumental development for the city of Grand Rapids. Inside, groundbreaking research and discovery will help drive innovation in the health care sector. Outside, human lives will be improved significantly thanks to the work of its tenants providing world-class health treatment for various types of cancer and diseases.
A MSU College of Human Medicine researcher has been awarded a federal grant to study a gene therapy treatment for cystic fibrosis, a potential cure for the rare, lethal disease that afflicts more than 30,000 people in the United States and 70,000 worldwide.
A new rare genetic syndrome went from a collection of symptoms to a successful treatment in less than two years with the help of three professors in the Department of Pediatrics and Human Development, André S. Bachmann, PhD, Caleb Bupp, MD, and Surender Rajasekaran, MD.
Michigan State University and BAMF Health announced the delivery of two advanced GE PETtrace 890 cyclotrons at the Doug Meijer Medical Innovation Building.
Bold Advanced Medical Future Health (BAMF) is expected to lease some 35,000 square feet in the new Doug Meijer Medical Innovation Building at the Michigan State University Grand Rapids Innovation Park.
Growth along Medical Mile in Grand Rapids brings jobs, innovation to area
Leaders from pharmaceutical manufacturer Perrigo and Michigan State University joined developers on April 14 for the Perrigo building groundbreaking ceremony.
Michigan State University's partnership with Perrigo recognized as winner of the Economic Development Category in the 2021 MiBiz Deal of the Year Awards.
Perrigo Co. plc moves its North American corporate offices to the Medical Mile. The pharmaceutical giant will occupy three upper floors of a building in Michigan State University’s Grand Rapids Innovation Park.
Over the last decade, medical and education institutions have invested more than $1 billion into Medical Mile, turning it into a world-class healthcare destination. In addition to many hospitals and research centers, Medical Mile is also home to educational institutions dedicated to medical science, such as Michigan State University.
Development has accelerated at Michigan State University's Grand Rapids Innovation Park, at the northwest corner of the city's Medical Mile.
Perrio and Michigan State University’s Grand Rapids Innovation Park enter a formal partnership to advance consumer self-care innovation.
A new partnership will connect Michigan State University’s clinical and research acumen with Perrigo Co. plc’s expertise in product innovation, manufacturing scale and retail distribution.
A study by Business Leaders for Michigan, “How university-led economic development can transform our state’s future," reviews how the move of MSU’s College of Human Medicine to downtown Grand Rapids has spurred a cluster of hospitals, research centers and job creation along Michigan Street.
Perrigo Company will establish its new North American Corporate Headquarters in downtown Grand Rapids. The new office will be constructed within Michigan State University’s Grand Rapids Innovation Park.
The Honorable Ambassador PETER F. SECCHIA (MSU ’63, Business), philanthropist and lead champion of the Michigan State University College of Human Medicine, died October 21, 2020, at the age of 83.
A major milestone was achieved at the Doug Meijer Medical Innovation Building in August.
See the latest progress of the Doug Meijer Medical Innovation Building construction.
Construction on the MSU Grand Rapids Innovation park has been permitted to continue under executive order as it is an essential public health infrastructure project. Read the full statement from Rockford Construction.
Health Innovation Partners and Michigan State University broke ground on the next phase of the university’s Grand Rapids Innovation Park, the Doug Meijer Medical Innovation Building.
A significant gift from Doug Meijer and the Meijer Foundation will support Michigan State University's vision of transforming health care via biomedical research.
Dr. David Morgan is leading new study called Preventing Alzheimer's with Cognitive Training, which looks at whether or not computerized training exercises or brain games can reduce the risk of dementia.
With the fall 2019 groundbreaking of the medical innovation building, Health Innovation Partners – a real estate development joint venture between MB Real Estate, Walsh Construction/Walsh Investors and Rockford Construction – and MSU will set the stage for a new era of medical innovation in Grand Rapids.
When Dr. Beauchamp looks to the future of biomedical research and healthcare, he describes what sounds like a health science utopia. But this place is not a utopian fantasy. It exists, its impact on human health is growing and it’s spurring life-saving discoveries. The place is Grand Rapids.
MSU researchers collaborated with the Van Andel Institute to identify a combination of two gene mutations that is linked to endometrial cancer. Led by Ronald Chandler, the study finds that mutations certain genes are frequently found together in the development of endometrial cancer.
Michigan State University’s first Public Private Partnership, or P3, is official. A long-term ground lease for the continued development of the Grand Rapids Research Center site includes construction for a medical innovation building and parking structure.
André Bachmann is creating treatments for children with rare medical conditions that many large pharmaceutical companies won’t develop due to high costs and low returns.The professor and associate chair for research in the MSU College of Human Medicine and his team are studying the therapeutic potential of existing drugs used to stop cancer growth in children with neuroblastoma — one of the most aggressive forms of pediatric cancer. It’s a novel approach that could lead to similar breakthroughs in medical genetics.
The Michigan State University Board of Trustees has authorized the university to enter into a Public Private Partnership, or P3, for the continued development of the Grand Rapids Research Center site.
A new era for scientific discovery was unveiled during a dedication and ribbon-cutting ceremony for Michigan State University’s $88.1 million Grand Rapids Research Center.
Watch the demolition of the Grand Rapids Press site beginning March 2015 through the construction of the Grand Rapids Research Center in July 2017.
The Michigan State University College of Human Medicine celebrated a construction milestone Nov. 19 with the “topping off” of the MSU Grand Rapids Research Center.
A new era of medical discovery began June 18, as ground was broken for the Michigan State University Grand Rapids Research Center.
The Michigan State University Board of Trustees authorized the administration to expand the university's research capabilities in Grand Rapids by constructing a biomedical research facility on the site of the former Grand Rapids Press building.
Michigan State University Board of Trustees has authorized the demolition of the former Grand Rapids Press building located in downtown Grand Rapids, Michigan, on property the university acquired in 2012.